Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach

Fig. 5

Representative histological examination (myoglobin and HE staining) of muscle atrophy in the hind limb ischemia mouse model (average value ± standard deviation). a After 91 days, significantly less signs of steatosis and (b) a significantly higher volume of muscle fibers were observed in the PCMO group compared to (c) the monocytes and placebo group pointing toward a putative regenerative effect of PCMO in ischemic muscle (**p ≤ 0.002; ***p < 0.0001). Scale bar 100 μm. PCMO programmable cells of monocytic origin

Back to article page